81270 Jak2 gene
Also known as: JAK2 mutation test, polycythemia vera genetic testing
Janus Kinase 2 (JAK2) gene mutation analysis to detect variants associated with myeloproliferative neoplasms including polycythemia vera.
In Plain Language
Blood cancer mutation test; Polycythemia vera screening
Clinical Context
Detects JAK2 mutations (especially V617F) in myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
RVU Information
CPT 81270 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81270?
CPT 81270 (Jak2 gene) is a Pathology & Lab code. Janus Kinase 2 (JAK2) gene mutation analysis to detect variants associated with myeloproliferative neoplasms including polycythemia vera.
Who uses CPT code 81270?
CPT 81270 is used by Pathology, Hematology, Oncology. Detects JAK2 mutations (especially V617F) in myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
When is CPT 81270 used?
Detects JAK2 mutations (especially V617F) in myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.